Catalyst Biosciences, Inc. (CBIO): Price and Financial Metrics
Catalyst Biosciences, Inc. (CBIO)
Today's Latest Price: $5.37 USD
Updated Oct 28 10:10am
Add CBIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CBIO Stock Summary
- For CBIO, its debt to operating expenses ratio is greater than that reported by only 5.81% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for Catalyst Biosciences Inc; that's greater than it is for just 11.35% of US stocks.
- Catalyst Biosciences Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -47.97%, greater than the shareholder yield of just 8.66% of stocks in our set.
- Stocks that are quantitatively similar to CBIO, based on their financial statements, market capitalization, and price volatility, are ETTX, ACIU, CDTX, SYBX, and LOGC.
- Visit CBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.catalystbiosciences.com.
CBIO Stock Price Chart Interactive Chart >
CBIO Price/Volume Stats
| Current price | $5.37 | 52-week high | $8.94 |
| Prev. close | $5.60 | 52-week low | $3.43 |
| Day low | $5.21 | Volume | 52,407 |
| Day high | $5.42 | Avg. volume | 281,126 |
| 50-day MA | $4.91 | Dividend yield | N/A |
| 200-day MA | $5.75 | Market Cap | 118.48M |
Catalyst Biosciences, Inc. (CBIO) Company Bio
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. The company is based in South San Francisco, California.
Loading social stream, please wait...